Company intelligence / Profile preview

Veltmeyer MD

Likely La Mesa or greater San Diego area (inferred from physician practice location), California, United States

Ownership: Private
Development stage: Other

Overview

Veltmeyer MD Inc. is a medical practice/clinic that collaborates with Res Nova Bio, a spin‑off of Therapeutic Solutions International, to provide access under the U.S. Right to Try law to the anti‑angiogenic cancer immunotherapy ValloVax, which has prior FDA IND clearance and safety data from clinical use.[2][6] The clinic’s role is provision of this experimental therapy to late‑stage breast cancer and other no‑option patients rather than sponsoring formal clinical trials.[2][6]

Therapeutic areas: Oncology
Modalities: Cell therapyVaccineImmunotherapyBiologic
Industry: Non-Academic Healthcare

Partnerships

Res Nova BioTherapeutic Solutions International

Beyond the preview

Go deeper on Veltmeyer MD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veltmeyer MD.

Explore the full profile